Calabasas Ketamine IV Infusion Therapy For Bipolar Disorder, Treatment Launched

Dec 5, 2023

Chrysalis Ketamine (888-836-4334) has launched a new ketamine infusion treatment for patients with bipolar disorder in the Calabasas area.

Thousand Oaks, United States - December 5, 2023 /PressCable/ —

The clinic’s recently launched ketamine IV therapy provides almost instantaneous relief from the symptoms of bipolar disorder. Traditional SSRIs, such as Fluvoxamine (Luvox), can take months to show results, whereas ketamine activates a different neurotransmitter yielding much faster results.

For more information, please visit https://chrysalisketamine.com/bipolar-disorder-thousand-oaks-ca/

According to research from the DBSA (Depression and Bipolar Support Alliance), bipolar disorder affects approximately 5.7 million adult Americans and is equally prevalent in men and women. Chrysalis Ketamine’s new IV therapy has quickly become one of the most popular treatments for bipolar disorder due to its ability to improve mood within hours.

As explained by Dr. Karpanian, “Ketamine helps with bipolar disorder by rapidly boosting the activity of glutamate, a neurotransmitter inside the frontal cortex of the human brain, while also allowing new pathways to form in the same area.” This treatment is often highly effective in treating bipolar disorder where other, more traditional, antidepressant medications or therapies have been ineffective.

“Ketamine treatment is remarkably different from conventional antidepressants, which ultimately boost serotonin activity levels in several areas of the brain to ultimately affect glutamate. This process usually takes weeks, sometimes months, while ketamine produces an almost instant result and relief from anxiety symptoms,” says the clinic.

Chrysalis Ketamine provides information on the different forms of bipolar disorder, including bipolar 1, bipolar 2 and cyclothymia. Those suffering from any of these disorder types will typically display manic and depressive episodes, explains the clinic, but it is essential for patients to verify their specific disorder in order to be prescribed the correct treatment.

The clinic provides private treatment rooms for those undergoing ketamine IV infusions, monitoring each patient throughout. Infusions last approximately one hour, with dosages carefully determined by the team according to each patient’s needs.

Dr. Karpanian explains that ketamine therapy works best when approached holistically, advising patients to retain good sleep, diet and exercise habits to ensure the most positive results. The clinic also offers patients a complimentary coaching session, entitled ‘Being True to You’, alongside their first ketamine treatment.

Interested parties can schedule a consultation with Chrysalis Ketamine to find out if ketamine therapy is right for them by visiting https://chrysalisketamine.com/

Contact Info:
Name: Hagop Karpanian
Email: Send Email
Organization: Chrysalis Ketamine
Address: 430 E Avenida De Los Arboles Suite 205, Thousand Oaks, California 91360, United States
Phone: +1-888-836-4334
Website: https://www.chrysalisketamine.com

Source: PressCable

Release ID: 89115407

In case of identifying any problems, concerns, or inaccuracies in the content shared in this press release, or if a press release needs to be taken down, we urge you to notify us immediately by contacting [email protected]. Our dedicated team will be readily accessible to address your concerns and take swift action within 8 hours to rectify any issues identified or assist with the removal process. We are committed to delivering high-quality content and ensuring accuracy for our valued readers.

More News

Weight Loss Drugs Give Restaurants a New Hurdle: Diners Who Eat Less
Oct 3, 2026
Weight Loss Drugs Give Restaurants a New Hurdle: Diners Who Eat Less

Fewer orders and higher costs are squeezing restaurants big and small as people on the weight-loss drugs eat and drink less when dining out.

Tech giants' AI boom faces a rising cash-flow test
Oct 3, 2026
Tech giants' AI boom faces a rising cash-flow test

The fiscal 2026 earnings cycle has underscored the extraordinary momentum behind the AI boom, with tech giants posting record revenues while their shares have also rallied. But beneath the headline numbers, a new test is emerging: how long can AI-driven cash generation keep pace with the massive investment required to expand computing capacity?

Trump Says Economy Has ‘Public Relations’ Problem Amid High Prices and Slow Hiring
Oct 3, 2026
Trump Says Economy Has ‘Public Relations’ Problem Amid High Prices and Slow Hiring

The president, who had hoped to tout a growing economy on the campaign trail, has found it hard to break through as workers’ wages fail to keep up.

Suppliers pile pressure on government over energy bills
Oct 3, 2026
Suppliers pile pressure on government over energy bills

Immediate action is needed to help households struggling with bills this winter, says trade body Energy UK.

America Wants to Make More Generic Drugs. India Shows Why That’s Hard.
Oct 3, 2026
America Wants to Make More Generic Drugs. India Shows Why That’s Hard.

Cheap labor and global supply chains are among the obstacles to President Trump’s plan to bring generic drug manufacturing back home.

New baby bank 'open to everybody'
Oct 3, 2026
New baby bank 'open to everybody'

The facility offers essential items for free, including clothes for babies and small children.

Rising energy costs add to cost of living for Northern Ireland's consumers
Oct 3, 2026
Rising energy costs add to cost of living for Northern Ireland's consumers

Households across Northern Ireland face increasing pressure on the cost of living as energy price hikes have come into effect.

G7 to release millions of barrels of oil and diesel after Trump threat
Oct 3, 2026
G7 to release millions of barrels of oil and diesel after Trump threat

The co-ordinated release is aimed at heading off further price spikes and avoiding a ban on US diesel exports.

White House Filing Claims President Has Authority to Bar News Outlets
Oct 3, 2026
White House Filing Claims President Has Authority to Bar News Outlets

The Trump administration again defended the decision to bar CNN, MS NOW and Politico from the White House and to exclude journalists from the pool that covers the president in small spaces.

Federal Watchdog Investigates Adam Kinzinger for Kalshi Bets on His Pardon
Oct 3, 2026
Federal Watchdog Investigates Adam Kinzinger for Kalshi Bets on His Pardon

The inquiry by the Commodity Futures Trading Commission centers on bets the former congressman made on Kalshi in the weeks before he was pardoned in January 2025.

US Sanctions A7, a Russia Firm That Helps Sidestep Economic Restrictions
Oct 3, 2026
US Sanctions A7, a Russia Firm That Helps Sidestep Economic Restrictions

The move followed reports detailing how A7, a Moscow firm, uses shell companies around the world to move funds for clients who are themselves subject to sanctions.

G20 trade ministers meet in Wisconsin amid trade tensions
Oct 2, 2026
G20 trade ministers meet in Wisconsin amid trade tensions

G20 trade ministers meet in Wisconsin amid trade tensions

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Marketers Log

Marketers Log is your personal Business & Finance news site to provide marketing or market-related news.

Newsletter